Идёт набор NCT06915168

CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

Без фазы С лечением Breast Carcinoma

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: Informational Intervention, Survey Administration.
Кому может быть актуально: Состояния в реестре: Breast Carcinoma. Базовые параметры: Без ограничений · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: США
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

CIPN Decision Aid to Improve Neurotoxic Chemotherapy Decision Making

Обзор

This clinical trial studies how well a chemotherapy-induced peripheral neuropathy (CIPN) decision aid works in improving chemotherapy decision making among patients with breast cancer. CIPN involves numbness or tingling in the hands or feet and is a debilitating side effect of several commonly used classes of cancer drugs. CIPN symptoms are typically minor at first but can progress with continued treatment to severe symptoms that can affect long-term function, falls risk, and quality of life. Symptoms sometimes resolve after treatment but in patients who experienced CIPN, symptoms are still present 1 year post-treatment in about two-thirds of patients and 3 years post-treatment in approximately half of the patients. Previous studies indicate patients lack awareness of long-term CIPN symptoms. A decision aid that provides information about permanent CIPN, that helps patients understand their treatment priorities, and prepares them for a discussion with their medical oncologist may lead to improvements in treatment decision making, satisfaction with decision making, and ultimately increase patient's achievement of their treatment goals.

Вмешательства

Другое Informational Intervention
Given CIPN DecisionAid
Другое Survey Administration
Ancillary studies

Первичные конечные точки

Change in decision preparedness [Срок оценки: up to 12 weeks]

Вторичные конечные точки (9)

Change in decision preparedness [Срок оценки: up to 12 weeks]
Change in awareness [Срок оценки: up to 12 weeks]
Change in discussion confidence [Срок оценки: up to 12 weeks]
Change in decision preparedness [Срок оценки: up to 12 weeks]
Change in decision empowerment [Срок оценки: up to 12 weeks]
Discussion satisfaction [Срок оценки: up to 12 weeks]
Decision satisfaction [Срок оценки: up to 12 weeks]
Helpfulness [Срок оценки: up to 12 weeks]
Taxane chemotherapy treatment decision [Срок оценки: up to 12 weeks]

Критерии участия

Критерии включения

Patients with breast cancer
Currently receiving cycle three of taxane treatment
Approval of medical oncologist to enroll patient
Experiencing any CIPN based on enrollment screening question, "In the last 7 days, what was the severity of your numbness or tingling in your hands or feet at its worst? None, Mild, Moderate, Severe, Very Severe. Patient is eligible if their answer is anything except "None"
Access to a smartphone or similar device that can complete CIPN DecisionAid via Qualtrics while in the waiting room